Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.
A candidate tumor suppressor gene, DPC4, located at 18q21.1, has recently been shown to be inactivated in half of pancreatic adenocarcinomas. The close developmental relationship of the pancreas and biliary tract prompted us to determine the role of DPC4 in the multistep carcinogenesis of biliary tract carcinoma. A search for mutations in the genomic sequence of the highly conserved COOH-terminal domain of DPC4 (exons 8-11) was performed by single-strand conformational polymorphism analysis. Five of 32 (16%) primary biliary tract carcinomas had point mutations in the DPC4 sequence. Interestingly, inactivation of DPC4 was especially common in carcinomas originating from the common bile duct (four of eight specimens analyzed), suggesting an important role for DPC4 in the development of this subtype of biliary tract tumor.
Hahn
S A
SA
Department of Internal Medicine, University of Bochum, Germany.
Bartsch
D
D
Schroers
A
A
Galehdari
H
H
Becker
M
M
Ramaswamy
A
A
Schwarte-Waldhoff
I
I
Maschek
H
H
Schmiegel
W
W
D000595:Amino Acid Sequence; D001661:Biliary Tract Neoplasms / Q000235:genetics*; D002277:Carcinoma / Q000235:genetics*; D004273:DNA, Neoplasm / Q000235:genetics; D004268:DNA-Binding Proteins; D016147:Genes, Tumor Suppressor; D006801:Humans; D008969:Molecular Sequence Data; D017354:Point Mutation; D018807:Polymorphism, Single-Stranded Conformational; D016415:Sequence Alignment; D017386:Sequence Homology, Amino Acid; D051901:Smad4 Protein; D015534:Trans-Activators / Q000235:genetics*
D004273:DNA, Neoplasm; D004268:DNA-Binding Proteins; C497796:SMAD4 protein, human; D051901:Smad4 Protein; D015534:Trans-Activators